The research unit FOR 2240 is set in a productive atmosphere for cooperation, including researcher-led associated projects.
There are strong connections to three large research networks funded by the European Union. The networks deal with inflammatory diseases of the cornea and/or the ocular surface.
- EU COST Action BM 1302 “Joining forces in corneal regeneration” (www.biocornea.eu) is led by Professor C. Cursiefen, University of Cologne, Germany and by Professor M. Jager, University of Leiden, The Netherlands.
- EU Horizon 2020 Project ARREST BLINDNESS (www.arrestblindness.eu) is led by Professor N. Lagali, University of Linköping, Sweden, with the Department of Ophthalmology, University of Cologne serving as the second largest partner.
- EU Innovative Training Network for Dry-eye Disease Drug Development (ITN-DED3-H2020-MSCA-ITN-2017) with Professor P. Steven, University of Cologne, Germany as Principal Investigator.
Center for Molecular Medicine Cologne, Project B3 “Novel therapeutic role of myeloid cell-derived VEGF-C and lymphangiogenesis in resolution of corneal inflammation and reestablishment of corneal transparency” Principal Investigators: Professor C. Cursiefen, PD Dr. F. Bock, Dr. Dr. D. Hos. Link to project page.
German Federal Ministry of Education and Research VIP+ program and North-Rhine Westphalia Patent Validation for the project “Polysialic acid: Expression in the human retina and therapeutic potential in the laser-damage mouse model”
German Research Foundation: “Molecular investigations of miR-29-associated deposits of extra-cellular matrix in the course of Fuchs endothelial dystrophy”, Principal Investigator: PD Dr. M. Matthaei.
German Federal Ministry of International Development and Cooperation, Klinikpartnerschaft with the National Academy of Science, Ukraine: Professor C. Cursiefen, Cologne: “Optimierte Transplantationschirurgie der Hornhaut gegen korneale Erblindung in der Ukraine”, (www.klinikpartnerschaften.de)